Cargando…

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue

Methylene blue is a phenothiazine-related heterocyclic aromatic molecule presently used in the treatment of methemoglobinemia. Recently, it has been implicated in the treatment of severe refractory vasoplegic shock caused by anaphylaxis, sepsis, or postcardiopulmonary bypass. We present a case of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manji, Farheen, Wierstra, Benjamin, Posadas, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642875/ https://www.ncbi.nlm.nih.gov/pubmed/29098094 http://dx.doi.org/10.1155/2017/8747326

Ejemplares similares

Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

Methylene Blue in Refractory Shock
por: Chalise, Som N, et al.
Publicado: (2022)

METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock
por: Jaiswal, Abhishek, et al.
Publicado: (2020)

After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
por: Petermichl, Walter, et al.
Publicado: (2021)

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study
por: Kofler, Othmar, et al.
Publicado: (2022)

The Efficacy of Albumin Dialysis in the Reversal of Refractory Vasoplegic Shock Due to Amlodipine Toxicity
por: Connor-Schuler, Randi L., et al.
Publicado: (2020)

Vasopressin in vasoplegic shock: A systematic review
por: Webb, Andrew J, et al.
Publicado: (2020)

The Effects of Methylene Blue on Hemodynamic Parameters and Cytokine Levels in Refractory Septic Shock
por: Park, Byung-Kyu, et al.
Publicado: (2005)

Methylene blue administration in patients with refractory distributive shock – a retrospective study
por: Porizka, Michal, et al.
Publicado: (2020)

Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock
por: Ranzani, Otavio Tavares, et al.
Publicado: (2013)

Timing of vasoactive agents and corticosteroid initiation in septic shock
por: Ammar, Mahmoud A., et al.
Publicado: (2022)

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

Stratifying septic patients using lactate: severe sepsis and cryptic, vasoplegic and dysoxic shock profile
por: Ranzani, Otavio T, et al.
Publicado: (2013)

Effects of methylene blue on gas exchange and myocardial function in refractory septic shock with acute lung injury
por: Andresen, M, et al.
Publicado: (1997)

Vasopressin in vasoplegic shock in surgical patients: systematic review and meta-analysis
por: Szeles, Taís Felix, et al.
Publicado: (2023)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review
por: Puntillo, Filomena, et al.
Publicado: (2020)

Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study
por: Rajbanshi, Lalit Kumar, et al.
Publicado: (2023)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

Methylene Blue to Neonatal Septic Shock treatment in neonate pigs(,)
por: Gonçalves-Ferri, Walusa Assad, et al.
Publicado: (2022)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature
por: Maier, Alexander, et al.
Publicado: (2019)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)

Effects of therapy with methylene blue on hemodynamics and gas exchange in septic shock
por: Donati, A, et al.
Publicado: (1997)

Effect of methylene blue on hemodynamic and metabolic response in septic shock patients
por: Luis-Silva, Fabio, et al.
Publicado: (2022)

Drug diluent and efficacy of methylene blue in septic shock: authors’ reply
por: Ibarra-Estrada, Miguel, et al.
Publicado: (2023)

Use of Methylene Blue in the Treatment of Refractory Vasodilatory Shock After Cardiac Assist Device Implantation: Report of Four Consecutive Cases
por: Michel, Sebastian, et al.
Publicado: (2012)

The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report
por: Elkhatib, Wiaam Y, et al.
Publicado: (2021)

Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review
por: Mirhosseini, Seyed Mohsen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_25rg3a2a5s5spfq1qtc074gfqd